DETECTION, SIGNIFICANCE AND TREATMENT OF PARAPROTEIN IN PATIENTS PRESENTING WITH IDIOPATHIC PROTEINURIA WITHOUT MYELOMA

被引：0
|
作者：
MALLICK, NP
DOSA, S
ACHESON, EJ
DELAMORE, IW
MCFARLANE, H
SENEVIRATNE, CJ
WILLIAMS, G
机构：
[1] MANCHESTER ROYAL INFIRM, DEPT CLIN HAEMATOL, MANCHESTER M13 9WL, LANCASHIRE, ENGLAND
[2] MANCHESTER ROYAL INFIRM, DEPT MED BIOCHEM, MANCHESTER M13 9WL, LANCASHIRE, ENGLAND
[3] MANCHESTER ROYAL INFIRM, DEPT PATHOL, MANCHESTER M13 9WL, LANCASHIRE, ENGLAND
[4] UNIV MANCHESTER, MANCHESTER M13 9PL, LANCASHIRE, ENGLAND
来源：
QUARTERLY JOURNAL OF MEDICINE | 1978年 / 47卷 / 186期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：145 / 175
页数：31
相关论文
共 50 条
  • [31] Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19)
    Beksac, Meral
    Tuglular, Tulin
    Gay, Francesca
    Mina, Roberto
    Katodritou, Eirini
    Unal, Ali
    Cavo, Michele
    Ozsan, Guner Hayri
    van der Velden, Vincent H. J.
    Beverloo, Berna
    Vermeulen, Michael
    van Duin, Mark
    Cengiz, Guldane
    Sevindik, Omur Gokmen
    Merante, Serena
    Manousou, Kyriaki
    Sonneveld, Pieter
    Terpos, Evangelos
    BLOOD, 2022, 140 : 10177 - 10179
  • [32] Detection and clinical significance of glomerular M-type phospholipase A2 receptor in patients with idiopathic membranous nephropathy
    Liu, H.
    Luo, W.
    Gong, S.
    Ding, X.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (11) : 1318 - 1322
  • [33] Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma
    Ablashi, DV
    Chatlynne, L
    Thomas, D
    Bourboulia, D
    Rettig, MB
    Vescio, RA
    Viza, D
    Gill, P
    Kyle, RA
    Berenson, JR
    Whitman, JE
    BLOOD, 2000, 96 (06) : 2304 - 2306
  • [34] The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment
    Yang, Zhaoyang
    Lin, Hua
    Wang, Zhen
    Rong, Lulu
    Zhang, Xuchen
    Wang, Lin
    Qin, Jianjun
    Xue, Xuemin
    Li, Yin
    Xue, Liyan
    BMC CANCER, 2022, 22 (01)
  • [35] Clinical significance of CD200 expression in newly diagnosed multiple myeloma patients and dynamic changing during treatment
    Shi, Qinglin
    Wu, Chao
    Han, Wenmin
    Zhao, Sishu
    Wu, Yujie
    Jin, Yuanyuan
    Qu, Xiaoyan
    Li, Jianyong
    Zhang, Run
    Chen, Lijuan
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 709 - 715
  • [36] Deficiency of blood dendritic cells in patients with multiple myeloma: Possible significance for prediction of response to first line treatment.
    Smolewski, Piotr
    Branicka, Agata
    Cebula, Barbara
    Urbanska-Rys, Halina
    Robak, Tadeusz
    BLOOD, 2006, 108 (11) : 347B - 347B
  • [37] Change in relative mobility of M protein following neuraminidase treatment in patients with multiple myeloma and monoclonal gammopathy of undetermined significance
    Kurihara, Y
    Iijima, S
    Fukushima, K
    Hosaka, T
    Shiba, K
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2004, 18 (03) : 182 - 186
  • [38] The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment
    Zhaoyang Yang
    Hua Lin
    Zhen Wang
    Lulu Rong
    Xuchen Zhang
    Lin Wang
    Jianjun Qin
    Xuemin Xue
    Yin Li
    Liyan Xue
    BMC Cancer, 22
  • [39] Detection of circulant monoclonal plasma cell in the peripheral blood of patients with newly diagnosed multiple myeloma and monoclonal gammopathies of uncertain significance
    Gervasi, F.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 110 - 110
  • [40] High daratumumab detection rate in multiple myeloma patients on Dara-KRd treatment by the exent® system
    Barnidge, D.
    Sakrikar, D.
    Kubicki, T.
    Derman, B.
    Iliev, V.
    Jakubowiak, A.
    Lakos, G.
    CLINICA CHIMICA ACTA, 2024, 558
12345